Search hospitals > Quebec > SHERBROOKE
Université de Sherbrooke
Claim this profileSHERBROOKE, Quebec J1H 5N4
Conducts research for Chronic Obstructive Pulmonary Disease
Conducts research for Obesity
Conducts research for Glioblastoma
Conducts research for Parkinson's Disease
Conducts research for Cancer
34 reported clinical trials
4 medical researchers
Summary
Université de Sherbrooke is a medical facility located in SHERBROOKE, Quebec. This center is recognized for care of Chronic Obstructive Pulmonary Disease, Obesity, Glioblastoma, Parkinson's Disease, Cancer and other specialties. Université de Sherbrooke is involved with conducting 34 clinical trials across 87 conditions. There are 4 research doctors associated with this hospital, such as Patrick Richard, MD, Édith Masse, MD, Eric E Turcotte, MD, and Serge LePage, MD.Top PIs
Patrick Richard, MDCentre de recherche du CHUS (CRCHUS), Division of Urology, CIUSSS de l'Estrie - CHUS (CIUSSSE-CHUS)7 years of reported clinical research
Studies Prostate Cancer
Studies Cancer
4 reported clinical trials
7 drugs studied
Édith Masse, MDUniversité de Sherbrooke4 years of reported clinical research
Studies Neonatal Resuscitation Training
Studies Education
2 reported clinical trials
4 drugs studied
Eric E Turcotte, MDUniversité deSherbrooke17 years of reported clinical research
Studies Traumatic Arthropathy
Studies Bone Cancer
2 reported clinical trials
2 drugs studied
Serge LePage, MDUniversity of Sherbrooke1 year of reported clinical research
Studies Heart Failure
1 reported clinical trial
3 drugs studied
Clinical Trials running at Université de Sherbrooke
Bone Cancer
Glioblastoma
Heart Failure
Osteoarthritis
Traumatic Arthropathy
Bone Disease
Acute Bacterial Skin and Skin Structure Infections
Infectious Diseases
Arthritis
Neonatal Resuscitation Training
NaF PET Imaging
for Bone Cancer
18F-sodium fluoride (18F-NaF) was already investigated numerous times in the last 40 years as a PET alternative to standard 99m-technetium-derived bone scintigraphy. However, lack of universal tracer availability and higher costs contributed to the failure of 18F-NaF to systematically supplant bone scintigraphy as a standard of care. Recently, an isotope shortage crisis occurred and evidenced the need to have non-reactor-derived alternatives for many nuclear medicine procedures, including bone scintigraphy. Since 18F-NaF is cyclotron-produced, it could become a necessary alternative to bone scintigraphy in case of another worldwide isotope shortage. The study aims to evaluate the safety profile of 18F-NaF injection. Moreover, a patient registry will be compiled in order to perform sub-studies on 18F-NaF diagnostic performance on diverse bone and articular diseases.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Université de Sherbrooke?
Université de Sherbrooke is a medical facility located in SHERBROOKE, Quebec. This center is recognized for care of Chronic Obstructive Pulmonary Disease, Obesity, Glioblastoma, Parkinson's Disease, Cancer and other specialties. Université de Sherbrooke is involved with conducting 34 clinical trials across 87 conditions. There are 4 research doctors associated with this hospital, such as Patrick Richard, MD, Édith Masse, MD, Eric E Turcotte, MD, and Serge LePage, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.